Vijayakumar Velu PhD
- Department of Pathology and Laboratory Medicine
Assistant Professor
- (404) 727-9423
- vvelu@emory.edu
- ENPRC
-
Emory National Primate Center
Pathology and Laboratory Medicine
954 Gatewood Road
Overview
Dr. Vijayakumar Velu completed his postgraduate (Microbiology) in 2000 at Madurai Kamaraj University, India. He received his Ph.D. in Medical Microbiology/ Immunology from the University of Madras in 2005, under the guidance of world-renowned scientist Dr.S.P. Thyagarajan. During his doctoral studies, he focused on HIV confection with viral hepatitis (particularly on HBV/HCV/HIV co-infection). He demonstrated that co-infection of viral hepatitis in HIV infected individuals is a major problem in India. He also investigated the safety and efficacy of a novel indigenous recombinant hepatitis B vaccine from India (Genevac-B, developed by the Serum Institute of India). He joined Emory Vaccine Center/Emory National Primate Center in the year 2005 and completed his postdoctoral training in 2010 with Dr. Rama Rao Amara, which focused on developing therapeutic strategies to enhance immune response during chronic HIV infection/therapeutic vaccination. His studies demonstrated that blockade of inhibitory receptor Programmed Death-1 (PD-1) using an anti-PD-1 antibody during chronic SIV infection restored functional anti-viral T/ B cells, reduced SIV/HIV viral RNA levels, and increased the host survival. As a co-inventor of the PD-1 technology, along with Dr. Rama Rao Amara and Dr. Rafi Ahmed, he got a US patent entitled: Methods for the treatment of Infections and Tumors; # 20150239972, and this PD-1 technology has been licensed to Genentech by Emory University.
He has been involved in HIV/AIDS Immunology, Pathogenesis, and Vaccine development studies for the past 20 years. He has authored or co-authored more than 125 peer-reviewed publications in this field, including some in the highest impact journals (Nature, The Journal of Clinical Investigation, Nature Communications, Proceedings of the National Academy of Sciences, Science Translation Medicine, etc.). He serves as an Academic Editor of Plos Pathogens, also serves as an Associate Editor of the Viral immunology section of the Frontiers in Immunology in addition he serves as an editorial member for the Vaccines and Therapeutic Development section of Pathogens (MDPI), BMC Infectious Disease, The open AIDS journal, etc. In addition, he served as a member of several study sections, including HIV Vaccine Research & Development (HIVRAD), HIV molecular Virology, Cell Biology and Drug Development (HVCD), Special Emphasis Panel (SEP), and Small Business Innovation Research (SBIR), at the National Institutes of Health (NIH).
Currently, his lab research is focused on the development of therapeutic strategies to enhance immune response during chronic HIV infection/therapeutic vaccination for HIV cure using non-human primates (NHPs). In addition, his lab also focuses on studying Mycobacterium tuberculosis infection in human and non-human primate models. He uses the rhesus macaque model to investigate the cellular dynamics of T and NK cells in Mtb (latent, active) and Mtb/SIV infection. Specific research includes the frequency, phenotype, and function of Tissue Resident T cells (TRMs), T follicular Helper cells, and NK cells in Mtb and Mtb/SIV co-infected macaques. His lab collaborates with several institutions in the United States and in India for HIV, Viral Hepatitis, and Mycobacterium tuberculosis studies. His lab strongly believes a better understanding of the roles of cellular mechanisms in generating effective immune responses that govern the induction of host resistance versus immunopathology is critical for successful immune intervention and rational design of more effective vaccines and immunotherapies for deadly diseases such as HIV/AIDS, Viral hepatitis and Mycobacterium tuberculosis.
Academic Appointment
- Assistant Professor, Pathology & Laboratory Medicine, Emory University School of Medicine
- Assistant Professor, Division of Microbiology and Immunology, Emory National Primate Research Center
Education
Degrees
- PhD Medical Microbiology and Immunology from University of Madras
- MSc Microbiology from Madurai Kamaraj University
- PG Diploma Pathology from Tamil Nadu Dr. M.G.R. Medical University
- BSc Biology from University of Madras
Research
Publications
-
Role of follicular homing natural killer cells in HIV infection.
Curr Opin HIV AIDS Volume: 20 Page(s): 154 - 158
03/01/2025 Authors: Ponnan SM; Govindaraj S; Velu V -
IL-15/IL-15Ra Synergies with IL-12 to Induce Functional CD8 T Cells and NK Cells During Chronic SHIV Infection.
AIDS Res Hum Retroviruses Volume: 41 Page(s): 120 - 123
03/01/2025 Authors: Govindaraj S; Ibegbu C; Ali SA; Babu H; Shanmugasundaram U; Villinger F; Amara RR; Velu V -
Mpox Virus as a Global Public Health Emergency: A Scoping Review.
Can J Infect Dis Med Microbiol Volume: 2025 Page(s): 6683501
01/01/2025 Authors: Sankar S; Balakrishnan P; Yong YK; Raju S; Velu V; Shankar EM; Larsson M -
Emergence of SARS-CoV-2 omicron variant JN.1 in Tamil Nadu, India - Clinical characteristics and novel mutations.
Sci Rep Volume: 14 Page(s): 17476
07/30/2024 Authors: Selvavinayagam ST; Sankar S; Yong YK; Murugesan A; Suvaithenamudhan S; Hemashree K; Rajeshkumar M; Kumaresan A; Pandey RP; Shanmugam S -
Occult hepatitis B virus infection and current perspectives on global WHO 2030 eradication.
J Viral Hepat Volume: 31 Page(s): 423 - 431
07/01/2024 Authors: Saravanan S; Shankar EM; Vignesh R; Ganesh PS; Sankar S; Velu V; Smith DM; Balakrishnan P; Viswanathan D; Govindasamy R -
Serosurveillance of dengue infection and correlation with mosquito pools for dengue virus positivity during the COVID-19 pandemic in Tamil Nadu, India - A state-wide cross-sectional cluster randomized community-based study.
medRxiv
06/09/2024 Authors: Selvavinayagam ST; Sankar S; Yong YK; Anshad AR; Chandramathi S; Somasundaram A; Palani S; Kumarasamy P; Azhaguvel R; Kumar AB -
Human Immunodeficiency Virus-Human Pegivirus Coinfected Individuals Display Functional Mucosal-Associated Invariant T Cells and Follicular T Cells Irrespective of PD-1 Expression.
Viral Immunol Volume: 37 Page(s): 240 - 250
06/01/2024 Authors: Vimali J; Yong YK; Murugesan A; Govindaraj S; Raju S; Balakrishnan P; Larsson M; Velu V; Shankar EM -
Emergence of SARS-CoV-2 Omicron Variant JN.1 in Tamil Nadu, India - Clinical Characteristics and Novel Mutations.
medRxiv
04/19/2024 Authors: Selvavinayagam ST; Sankar S; Yong YK; Murugesan A; Suvaithenamudhan S; Hemashree K; Rajeshkumar M; Kumaresan A; Pandey RP; Shanmugam S -
Chronic Viral Infection Compromises the Quality of Circulating Mucosal-Associated Invariant T Cells and Follicular T Helper Cells via Expression of Inhibitory Receptors.
Front Biosci (Landmark Ed) Volume: 29 Page(s): 128
03/22/2024 Authors: Vimali J; Yong YK; Murugesan A; Tan HY; Zhang Y; Ashwin R; Raju S; Balakrishnan P; Larsson M; Velu V -
Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India-A state-wide prospective longitudinal study.
J Med Virol Volume: 96 Page(s): e29456
02/01/2024 Authors: Selvavinayagam ST; Suvaithenamudhan S; Yong YK; Hemashree K; Rajeshkumar M; Kumaresan A; Arthydevi P; Kannan M; Gopalan N; Vignesh R